Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
Glavni autor: | Moreino, Shannon Sherwin |
---|---|
Daljnji autori: | Kabir, Eva Rahman |
Format: | Project report |
Jezik: | English |
Izdano: |
BRAC University
2018
|
Teme: | |
Online pristup: | http://hdl.handle.net/10361/9331 |
Similar Items
-
Biologics and Biosimilars as Treatment Options for Psoriasis
od: Moya, Amena Khatun
Izdano: (2023) -
Biosimilar in lymphoma treatment
od: Tanisha, Mehrin Haque
Izdano: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
od: Tabassum, Turana
Izdano: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
od: Tania, Umme
Izdano: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Izdano: (2023)